Loews Corp Has $8.03 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Loews Corp reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 52.4% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,000 shares of the company’s stock after selling 27,500 shares during the period. HCA Healthcare accounts for approximately 0.1% of Loews Corp’s holdings, making the stock its 16th largest holding. Loews Corp’s holdings in HCA Healthcare were worth $8,032,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. FinTrust Capital Advisors LLC grew its position in shares of HCA Healthcare by 26.7% in the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after purchasing an additional 35 shares during the period. Financial Counselors Inc. boosted its stake in HCA Healthcare by 1.4% in the 1st quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock worth $881,000 after purchasing an additional 36 shares during the period. Premier Path Wealth Partners LLC lifted its holdings in shares of HCA Healthcare by 2.7% in the second quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company’s stock valued at $448,000 after purchasing an additional 36 shares in the last quarter. Westside Investment Management Inc. raised its holdings in shares of HCA Healthcare by 14.7% in the second quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock valued at $93,000 after purchasing an additional 37 shares during the last quarter. Finally, ZWJ Investment Counsel Inc. boosted its stake in shares of HCA Healthcare by 3.5% during the 2nd quarter. ZWJ Investment Counsel Inc. now owns 1,082 shares of the company’s stock worth $348,000 after buying an additional 37 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Insiders sold a total of 8,844 shares of company stock worth $3,185,932 in the last three months. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Royal Bank of Canada raised their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Deutsche Bank Aktiengesellschaft increased their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a report on Monday, August 19th. JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research report on Thursday, May 30th. Finally, Truist Financial increased their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Four research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $356.17.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded up $2.80 during trading on Friday, reaching $395.59. 884,271 shares of the company traded hands, compared to its average volume of 1,126,563. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $395.91. The firm has a market capitalization of $103.61 billion, a PE ratio of 19.72, a PEG ratio of 1.39 and a beta of 1.68. The company’s 50 day moving average is $348.60 and its two-hundred day moving average is $332.96.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.29 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 22.43 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be paid a $0.66 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.67%. HCA Healthcare’s payout ratio is currently 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.